biocon semaglutide Halts China Launch of Drugs as Wegovy Eyes India Ajanta Pharma & Biocon Partner

Tirzepatide (Mounjaro) is a dual-action drug that not only acts on the GLP1a receptor but also the glucose-dependent insulinotropic polypeptide (GIP) receptor, giving (potentially) more potent effects

SpaceXs initial results put Musks AI spending under investor scrutiny Australia hikes 2.5% tech levy for giants failing to strike local news deals CXMT plans second Beijing chip plant: Report US, Japan launch rare joint effort to strengthen Yen for first time in nearly 30 years Japan to announce joint Tokyo-Washington action on yen 'Will SpaceX paint its rocket pink?' Investors quiz SpaceX ahead of first earnings Apple shares plunge as component squeeze triggers $500 billion market wipeout Alibaba computing deal gives Moonshot access to Nvidia chip cluster

This approach also helps maintain stable energy and makes it easier to reach daily protein targets when appetite is suppressed

Semeniuk, J., Shalansky, K